Entity
  • Innate Pharma

    Created in 1999


  • Up & running (A)
    Existing signals show a regular activity
  • Social networks

    4,094 27,354
  • Activities

  • Technologies

  • Entity types

  • Location

    117 Av. de Luminy, 13009 Marseille, France

    Marseille

    France

  • Employees

    Scale: 201-500

    Estimated: 196

  • SIREN

    424365336
  • Engaged corporates

    26
    0 0
  • Added in Motherbase

    5 years, 1 month ago
Description
  • Value proposition

    Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

    Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

    Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

    Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

    biotechnologies, antibodies, immunotherapy, and oncology

  • Original language

    Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

    Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

    Innate has been a pioneer in the understanding of natural killer cell (NK cell) biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

    Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.

Corporate interactions
Corporate TypeTweets Articles
Europe 1
Europe 1
Broadcast Media Production and Distribution
Europe 1
Broadcast Media Production and Distribution
Other

5 Feb 2025


Maison du doctorat - Université Paris-Saclay Maison du doctorat - Université Paris-Saclay
Research, Higher Education
Other

30 Jan 2025


J.P. Morgan J.P. Morgan
Bank
Other

10 Jan 2025


CMS Francis Lefebvre Avocats CMS Francis Lefebvre Avocats
Law Practice
Other

29 Dec 2024


Morgan Stanley
Morgan Stanley
Finance, Bank
Morgan Stanley
Finance, Bank
Other

6 Sep 2023


Gustave Roussy
Gustave Roussy
Health, Hospitals and Health Care
Gustave Roussy
Health, Hospitals and Health Care
Other

12 Feb 2025


L'Oréal
L'Oréal
Cosmetics, Personal Care Product Manufacturing
L'Oréal
Cosmetics, Personal Care Product Manufacturing
Other

4 Dec 2023


Takeda
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Takeda
Pharmaceutical, Pharmaceutical Manufacturing
Other

4 Apr 2023


Tech Nation
Tech Nation
Software Development
Tech Nation
Software Development
Other

31 Jul 2022


La French Tech Aix-Marseille Région Sud
La French Tech Aix-Marseille Région Sud
French Tech, Software Development
La French Tech Aix-Marseille Région Sud
French Tech, Software Development
Other

26 Mar 2019


Similar entities
Loading...
Loading...
Social network dynamics